Pharming Group N.V.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Pharming Group N.V. generated cash of -$17,302,000, which is less than the previous year. Cash used in financing activities reached the amount of -$1,039,000 last year. Net change in cash is therefore -$145,601,000.
Cash Flow
| 2014 | -6.41M | -795.27K | 21.88M |
|---|---|---|---|
| 2015 | -17.95M | -981.78K | 15.70M |
| 2016 | -10.52M | -60.44M | 70.80M |
| 2017 | 45.84M | -7.25M | -3.90M |
| 2018 | 46.18M | -4.31M | -20.54M |
| 2019 | 74.55M | -28.24M | -62.32M |
| 2020 | 90.97M | -16.82M | 65.32M |
| 2021 | 36.12M | -20.33M | -26.67M |
| 2022 | 22.89M | 5.32M | -4.98M |
| 2023 | -17.30M | -129.38M | -1.03M |
PHAR Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 207.34M | 191.92M | 189.15M | 81.54M | 91.31M | 68.62M | 38.55M | 33.48M | 37.59M | 23.28M |
Operating activities | ||||||||||
Net income | -12.01M | 14.98M | 22.03M | 47.46M | 68.22M | 43.45M | 26.28M | -12.13M | -9.95M | -5.76M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 15.92M | 13.18M | 18.72M | 8.94M | 5.79M | 7.50M | 4.09M | 795.08K | 0 | 0 |
Stock-based compensation expense | 9.25M | 6.39M | 9.05M | 6.53M | 4.44M | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 9.25M | 6.39M | 9.05M | 6.53M | 4.44M | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -16.79M | 2.20M | 0 | 0 | -6.95M | 0 | 0 | 0 | 0 | 0 |
Inventories | -14.43M | -15.01M | -5.87M | -3.39M | 3.43M | 1.16M | -471.48K | -1.80M | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -17.30M | 22.89M | 36.12M | 90.97M | 74.55M | 46.18M | 45.84M | -10.52M | -17.95M | -6.41M |
Investing activities | ||||||||||
Purchases Of Investments | -382.01M | 0 | -4.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.46M | -1.97M | -15.95M | -16.46M | -25.44M | -4.31M | -7.25M | -1.59M | -981.78K | -187.26K |
Acquisitions Net | 0 | 7.3M | 0 | -354.22K | -2.80M | 0 | 0 | -58.85M | 0 | -608.00K |
Cash generated by investing activities | -129.38M | 5.32M | -20.33M | -16.82M | -28.24M | -4.31M | -7.25M | -60.44M | -981.78K | -795.27K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 2.28M | 4.50M | 3.00M | 3.11M | 12.00M | 8.19M | 9.28M | 528.06K | 23.56M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -4.64M | -3.09M | -3.14M | -63.95M | -37.39M | -19.89M | 1.36M | -5.14M | 0 | -829.32K |
Cash used in financing activities | -1.03M | -4.98M | -26.67M | 65.32M | -62.32M | -20.54M | -3.90M | 70.80M | 15.70M | 21.88M |
Net Change In Cash | -145.60M | 15.41M | 2.56M | 123.94M | -14.50M | 24.61M | 33.41M | 309.2K | -2.77M | 18.52M |
Cash at end of period | 61.74M | 207.34M | 191.72M | 205.48M | 76.80M | 93.24M | 71.97M | 33.79M | 34.81M | 41.81M |
| Data source | Data source | Data source | Data source |